Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees stock surge to highest level since 2015 amid optimism about its strategy and pipeline.
Expedia Group reports strong Q2 2025 results, raises full-year guidance amid international gains, sending shares higher.
Federal probe investigates NY AG Letitia James over civil rights violations in high-profile cases against Trump and NRA.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees stock surge to highest level since 2015 amid optimism about its strategy and pipeline.
Expedia Group reports strong Q2 2025 results, raises full-year guidance amid international gains, sending shares higher.
Federal probe investigates NY AG Letitia James over civil rights violations in high-profile cases against Trump and NRA.